Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Receivables: 2020-2025

Historic Change in Receivables for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to -$255,059.

  • iSpecimen's Change in Receivables fell 407.96% to -$255,059 in Q3 2025 from the same period last year, while for Sep 2025 it was -$858,078, marking a year-over-year decrease of 85.13%. This contributed to the annual value of $903,329 for FY2024, which is 260.03% up from last year.
  • Latest data reveals that iSpecimen reported Change in Receivables of -$255,059 as of Q3 2025, which was up 15.72% from -$302,646 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Change in Receivables ranged from a high of $1.6 million in Q1 2023 and a low of -$1.4 million during Q2 2023.
  • In the last 3 years, iSpecimen's Change in Receivables had a median value of -$93,040 in 2024 and averaged -$88,255.
  • As far as peak fluctuations go, iSpecimen's Change in Receivables surged by 431.65% in 2021, and later tumbled by 708.19% in 2025.
  • iSpecimen's Change in Receivables (Quarterly) stood at $410,978 in 2021, then plummeted by 311.73% to -$870,148 in 2022, then declined by 5.19% to -$915,269 in 2023, then skyrocketed by 149.34% to $451,570 in 2024, then crashed by 407.96% to -$255,059 in 2025.
  • Its last three reported values are -$255,059 in Q3 2025, -$302,646 for Q2 2025, and -$751,943 during Q1 2025.